Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KENGREAL safely and effectively. See full prescribing information for KENGREAL. KENGREAL® ( c angrelor) for injection, for intravenous use Initial U.S. Approval: 201 5
Medication labelWhy this: Advisory · dailymed-prescription
KENGREAL is indicated as an adjunct to percutaneous coronary intervention (PCI) to reduce the risk of periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST) in patients who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor [see Clinical Studies ( 14.1 )].
- generic_name
- cangrelor
- product_names
- cangrelor
- ndc
- 10122-620, 10122-620-01, 10122-620-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en